跳至主要内容
临床试验/ACTRN12618002032235
ACTRN12618002032235招募中未知

se of advanced magnetic resonance imaging (MRI) technology to improve understanding and diagnosis of the major neurodegenerative diseases.

niversity of Queensland0 个研究点目标入组 400 人开始时间: 2018年12月19日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
40 Years 至 80 Years(—)
性别
All

入选标准

  • oVisual and auditory acuity, adequate for neuropsychological testing
  • oEnglish language proficiency, adequate for comprehensive neuropsychological testing
  • oWilling to undergo repeated MRIs (3T and 7T MRIs)
  • oHealthy control: without any history of neurological or major psychiatric illness; and who are free of any cognitive symptoms (e.g. Mini Mental State Exam (MMSE) score greater than or equal to 26/30, Addenbrooke’s Cognitive Examination (ACE) score greater than or equal to 88/100, Clinical Dementia Rating (CDR) equal to 0 ) ; and whose general health is good enough to lie comfortably in an MRI scanner (e.g. does not have severe arthritis or breathlessness etc.)
  • oPatients group will be divided into 7 different subgroups based on their clinical diagnosis.*
  • oPatient Group 1: Alzheimer’s disease (AD), including prodromal states such as mild cognitive impairment
  • oPatient Group 2: Parkinson’s disease (PD) patients
  • oPatient Group 3: Dementia with Lewy Bodies (DLB)
  • oPatient Group 4: Frontotemporal dementia (FTD)
  • oPatient Group 5: Progressive supranuclear palsy (PSP)
  • oPatient Group 6: Corticobasal degeneration (CBD), including patients with undifferentiated akinetic/rigid syndromes, i.e. where the assessing neurologist is confident of a degenerative disease but where the clinical features preclude a more precise diagnosis such as PD, PSP, CBD
  • oPatient Group 7: Amyotrophic lateral sclerosis (ALS)
  • o* Diagnosis will be based on patient and carer interview & questionnaire, physical examination, brain scans, cognitive tests (MMSE, ACE, CDR) and/or motor function tests (ALS functional rating scale revised (ALSFRS-R), Unified Parkinson’s disease rating scale (UPDRS), Hoen and Yahr).

排除标准

  • oPregnancy#
  • oKnown history of claustrophobia#
  • oContra-indication to MRI#: cardiac pacemakers, aneurysm clips, metal implants, hearing aid/implant, electrical neurostimulators, joint replacement etc. in accordance with the standard operating procedures of the Centre for Advanced Imaging, UQ. #NOTE: Participants will be re-interviewed by a radiographer on the day of imaging at the Centre for Advanced Imaging, UQ.
  • oHistory of other neurological diseases (including clinical stroke, multiple sclerosis, tumour, epilepsy, or any other disease) that could confound interpretation of the MRI scan data
  • oHistory of major psychiatric illness (psychosis, major depression)
  • oAny medical condition that could make scanning hazardous/uncomfortable (e.g. difficulty lying flat due to cardiac, respiratory or rheumatological disease)
  • oFor the patient group only
  • oUnavailability of a close relative/companion who can assist the patient to attend the research facility.
  • oAdvanced cognitive impairment rendering the patient untestable on neuropsychological tests or unable to follow the instructions for MRI scanning.

研究者

发起方
niversity of Queensland

相似试验